作者
Solmaz Shirjang, Behzad Mansoori, Ali Mohammadi, Neda Shajari, Pascal HG Duijf, Souzan Najafi, Fereydoon Abedi Gaballu, Katayoon Nofouzi, Behzad Baradaran
发表日期
2020/7
期刊
Advanced pharmaceutical bulletin
卷号
10
期号
3
页码范围
444
出版商
Tabriz University of Medical Sciences
简介
Purpose: Based on WHO report, colorectal cancer (CRC) is the second cause of death among patients with cancer worldwide. Dysregulation of miRNAs expressions has been demonstrated in different human cancers, especially CRC. Studies have shown that miR-330 could act as both TS-miR and/or oncomiR in different types of cancers. BACH1 is also identified as a transcription factor, which is involved in ontogenesis. In this study, we evaluated the CRC suppression via silencing of BACH1 by small silencer molecule called miR-330.
Methods: Firstly, we analyzed the BACH1, miR-330-3p and miR-330-5p expressions according to the colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) project established from a patient of the colon and rectal cancer patients in The Cancer Genome Atlas (TCGA) database. The targeting of BACH1 via miR-330 in human CRC cells was evaluated by Vejnar …
引用总数
2020202120222023202419746
学术搜索中的文章
S Shirjang, B Mansoori, A Mohammadi, N Shajari… - Advanced pharmaceutical bulletin, 2020